CL2014000104A1 - Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico - Google Patents

Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico

Info

Publication number
CL2014000104A1
CL2014000104A1 CL2014000104A CL2014000104A CL2014000104A1 CL 2014000104 A1 CL2014000104 A1 CL 2014000104A1 CL 2014000104 A CL2014000104 A CL 2014000104A CL 2014000104 A CL2014000104 A CL 2014000104A CL 2014000104 A1 CL2014000104 A1 CL 2014000104A1
Authority
CL
Chile
Prior art keywords
photosensitive material
pharmaceutical product
exposure
analysis
inner chamber
Prior art date
Application number
CL2014000104A
Other languages
English (en)
Spanish (es)
Inventor
Jeremy Guo
Deborah Shnek
Paula Spencer
Li Sun
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2014000104A1 publication Critical patent/CL2014000104A1/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • B65D79/02—Arrangements or devices for indicating incorrect storage or transport
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
CL2014000104A 2011-09-02 2014-01-14 Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico CL2014000104A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161530824P 2011-09-02 2011-09-02

Publications (1)

Publication Number Publication Date
CL2014000104A1 true CL2014000104A1 (es) 2014-07-25

Family

ID=46982918

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000104A CL2014000104A1 (es) 2011-09-02 2014-01-14 Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico

Country Status (13)

Country Link
US (1) US20140315187A1 (zh)
EP (1) EP2750989A1 (zh)
JP (1) JP2014529473A (zh)
KR (1) KR20140058669A (zh)
CN (1) CN103917458A (zh)
AU (1) AU2012301656A1 (zh)
BR (1) BR112014004591A2 (zh)
CA (1) CA2840637A1 (zh)
CL (1) CL2014000104A1 (zh)
EA (1) EA201490555A1 (zh)
MX (1) MX2014002533A (zh)
WO (1) WO2013033600A1 (zh)
ZA (1) ZA201309704B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202785A1 (en) 2015-06-17 2016-12-22 Novozymes A/S Container
IL250601B (en) * 2017-02-14 2018-05-31 Marpaz Tech Ltd Container for light sensitive material
AU2020224630A1 (en) * 2019-02-22 2021-08-05 The Chemours Company Fc, Llc Methods for determining photosensitive properties of a material

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
EP0117390B1 (en) * 1983-02-25 1990-09-05 Lifelines Technology, Inc. Process for monitoring incremental environmental exposures of products that undergo progressive quality changes in response to environment stimuli
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP0417563B1 (de) 1989-09-12 2000-07-05 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5962406A (en) 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
JPH06174600A (ja) * 1992-09-16 1994-06-24 Caterpillar Inc 状態変化を表示する方法および装置
CA2146559A1 (en) 1992-10-23 1994-05-11 Melanie K. Spriggs Methods of preparing soluble, oligomeric proteins
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
AU708239B2 (en) 1995-06-29 1999-07-29 Immunex Corporation Cytokine that induces apoptosis
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001036637A1 (en) 1999-11-17 2001-05-25 Immunex Corporation Receptor activator of nf-kappa b
AU2001259432B2 (en) 2000-05-03 2005-04-21 Amgen Inc. Modified peptides, comprising an FC domain, as therapeutic agents

Also Published As

Publication number Publication date
CA2840637A1 (en) 2013-03-07
JP2014529473A (ja) 2014-11-13
ZA201309704B (en) 2014-08-27
AU2012301656A1 (en) 2014-01-16
EA201490555A1 (ru) 2014-07-30
WO2013033600A1 (en) 2013-03-07
MX2014002533A (es) 2014-08-26
BR112014004591A2 (pt) 2017-03-28
EP2750989A1 (en) 2014-07-09
KR20140058669A (ko) 2014-05-14
US20140315187A1 (en) 2014-10-23
CN103917458A (zh) 2014-07-09

Similar Documents

Publication Publication Date Title
NO2017006I1 (no) Elbasvir eller et farmasøytisk akseptabelt stoff derav
NO2017004I2 (no) Grazoprevir eller et farmasøytisk akseptabelt stoff derav
CL2015000483A1 (es) Compuestos derivados biciclicos fusionados de sulfamoilo; composicion farmaceutica que los comprende; y producto que los contiene.
BRPI1006887A2 (pt) revestimento exterior reutilizável para um artigo absorvente
CL2015001511A1 (es) Proceso para producir un material de empaque revestido y material de empaque que tiene al menos una capa de barrera para compuestos hidrofóbicos.
EP3201607A4 (en) Imaging a target fluorophore in a biological material in the presence of autofluorescence
EP3115430A4 (en) Laminate adhesive, method for manufacturing laminate film, laminate film, and retort pouch material
BRPI0919044A2 (pt) conjunto de recipientes de dose de pó seco, inalador de pó seco, e, método para fabricar um conjunto de recipientes de dose
SG10201602829PA (en) Multilayer Thin Film Drug Delivery Device And Methods Of Making And Using The Same
CO6821959A2 (es) Formas de dosificación farmacéutica intranasales que comprenden naloxona
DK2582520T3 (da) UV-stråling-permeabel flerlagsfolie
DK2775986T3 (da) Filmemballage til orale biologiske stoffer
CL2014001016A1 (es) Compuestos triciclicos condensados y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende; y su uso en el tratamiento de una infeccion viral.
IL229166A0 (en) A coating composition suitable for dosage forms of drugs or food supplements
IL228397A0 (en) A coating preparation suitable for dosage forms of pharmaceuticals or nutritional supplements
EP3239579A4 (en) Multilayered tube for transporting liquid medicine and polyamide resin composition
CL2013003756A1 (es) Aparato de fabricacion de prenda de lamina para la fabricacion de una prenda de lamina para un articulo absorbente que comprende una pieza de cilindro que tiene una superficie externa que es generalmente cilindrica alrededor de un eje de rotacion a lo largo de uan direccion horizontal.
ES2641042T8 (es) Procedimiento para la fabricación de un fármaco proteínico
EP3368010A4 (en) SOLID DOSAGE FOR IMMEDIATE ACTIVE COMPOSITION AND DEVICE AND METHOD FOR THE PRODUCTION THEREOF
CL2014000104A1 (es) Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico
BR112014000217A2 (pt) formulação e método para a criação de uma formulação que estabiliza a proteína terapêutica
IT201600078604A1 (it) Gruppo di trasporto per confezioni di contenitori ad uso farmaceutico
CL2008000609A1 (es) Metodo para sanear productos de animales que comprende la aplicacion de fagos a una capa externa de un cuerpo de un animal.
DK2387349T3 (da) Fremgangsmåde til inspektion af indersiden af en snæver slange eller et snævert rør, især til medicinsk brug
EP3411024A4 (en) ORAL PHARMACEUTICAL FORM OF LOXAPIN WITH FILM